International Journal of Pharmacy and Chemistry

Special Issue

Latest Developments in Alzheimer's Treatment

  • Submission Deadline: 16 August 2024
  • Status: Open for Submission
  • Lead Guest Editor: Özden Tarı
About This Special Issue
Alzheimer's disease, the most common form of dementia, is a complex disease characterized by memory loss and other cognitive problems. Understanding the pathophysiology of Alzheimer's disease, which has an increasing prevalence, and investigating the structures of compounds that are effective in the treatment of this disease will help to develop new effective drug molecules. In this sense, it is of great importance to investigate the hypotheses that are effective on the disease, the structure of the active compounds, and their mechanisms of action. Recent studies have shown that focus on obtaining stronger compounds that can affect more than one of the hypotheses that are effective in the pathology of the disease.
The primary goal of this special issue is to the important hypotheses that play a role in the pathology of Alzheimer's disease and the structures of drug candidates and active compounds with proven anti-Alzheimer activity over these hypotheses are revealed.
We invite contributions that explore Alzheimer's disease, with particular interest in active compounds for Alzheimer's treatment.

Potential topics include, but are not limited to:

  • Alzheimer
  • Alzheimer's Treatment
  • Anti-Alzheimer Drugs
  • Potential Anti-Alzheimer Compounds
  • Alzheimer’s Pathology
  • Anti-Alzheimer Natural Products
  • Drug Candidates for the Treatment of Alzheimer's Disease
  • Types of articles welcomed: Original research articles, review articles, case studies, etc.
    Through this special issue, we aim to the reveal pathology of Alzheimer's disease and the Latest Developments in Alzheimer's Treatment. We welcome researchers from various disciplines to provide interdisciplinary perspectives on Alzheimer's Treatment. Your contributions will play a crucial role in advancing knowledge in this field.
    Lead Guest Editor
    • Özden Tarı

      Pharmaceutical Chemistry/Faculty of Pharmacy, Çukurova University, Adana, Turkey

    Guest Editors
    • Eda Kumcu

      Pharmacology/Faculty of Medicine,Cukurova University, Adana, Turkey

    • Tansu Yalçın

      Pharmaceutical Chemistry /Faculty of Pharmacy, Cukurova University, Adana, Turkey

    • Anıl Yirün

      Toxicology/Faculty of Pharmacy, Cukurova University, Adana, Turkey

    • Göksun Demirel

      Toxicology/Faculty of Pharmacy, Cukurova University, Adana, Turkey

    • Serpil Demirci Kayıran

      Pharmaceutical Botanical/Faculty of Pharmacy, Cukurova University, Adana, Turkey

    • Didem Yılmaz Ural

      Pharmacology /Faculty of Pharmacy, Cukurova University, Adana, Turkey

    Manuscript Submission

    Submitting your research to special issue is a simple and efficient process. Here are three submission options available:

    Option 1: Quick Submission

    Our Quick Submission tool provides a fast and uncomplicated way for you to submit your manuscripts.

    Selected Special Issue:*
    Special Issue Title Article Processing Charge
    Latest Developments in Alzheimer's Treatment 770 USD
    Article Title: *
    Upload Manuscript:*

    1. Allow only .doc, .docx and .tex format.
    2. Files should not exceed 20MB.

    Article Type: *
    First Name:*
    Last Name:*
    Email Address:*

    A follow-up email will be sent to the given email address within 3 working days.

    Verification Code: *
    Option 2: Online Submission

    Submit your manuscript via our online submission system.

    For unregistered users, please register at
    For registered users, please log in at

    Once you're logged in, click on "Submit to Special Issue" under the "Submission" section. Follow the system prompts to successfully complete the submission.

    Option 3: Email Submission

    You can submit your manuscript directly via email to

    Please type "Latest Developments in Alzheimer's Treatment Manuscript Submission" as the subject of your email.